Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
6
×
deals
6
×
life sciences
6
×
national blog main
national top stories
roche
6
×
boston blog main
boston top stories
fda
investing
san francisco blog main
san francisco top stories
boston
cancer
amgen
bristol-myers squibb
eli lilly
europe blog main
national
novartis
pfizer
rna interference
takeda pharmaceutical
venture capital
a2 biotherapeutics
acquisitions
aduro biotech
advanced therapies
agency
akili interactive labs
alexion pharmaceuticals
alicia hager
alnylam pharmaceuticals
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
arca biopharma
arch venture partners
arrowhead pharmaceuticals
What
drug
medicines
cancer
crispr
gene
research
roche
team
therapeutics
access
advanced
alliance
analytics
approval
bio
biofourmis
blueprint
bristol
buy
calls
candidate
capacity
car
caught
causing
cell
changing
color
consolidation
currently
data
days
despite
devices
dicerna
digital
disease
employs
eye
falcon
Language
unset
6
×
Current search:
roche
×
unset
×
deals
×
" life sciences "
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug